Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.340
+0.010 (0.43%)
At close: Oct 28, 2025, 4:00 PM EDT
2.380
+0.040 (1.71%)
After-hours: Oct 28, 2025, 5:43 PM EDT

Jasper Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
653218822389125
Upgrade
Market Cap Growth
-70.61%264.33%294.73%-94.26%210.66%-
Upgrade
Enterprise Value
29230-13-2529198
Upgrade
Last Close Price
2.3321.387.894.8378.50100.10
Upgrade
PB Ratio
1.615.201.120.625.5914.37
Upgrade
P/TBV Ratio
2.805.201.120.625.59-
Upgrade
Debt / Equity Ratio
0.090.030.040.100.040.19
Upgrade
Quick Ratio
1.934.707.045.5410.635.09
Upgrade
Current Ratio
2.104.977.195.9110.955.16
Upgrade
Return on Equity (ROE)
-146.87%-101.73%-112.67%-71.44%-78.33%-212.46%
Upgrade
Return on Assets (ROA)
-73.30%-54.52%-60.09%-45.06%-39.35%-51.13%
Upgrade
Return on Capital (ROIC)
-91.65%-65.85%-71.22%-57.12%-55.65%-82.24%
Upgrade
Earnings Yield
-137.97%-22.22%-73.23%-168.98%-7.88%-25.31%
Upgrade
FCF Yield
-112.07%-19.69%-59.45%-208.21%-9.29%-14.60%
Upgrade
Buyback Yield / Dilution
-19.90%-39.72%-186.15%-220.19%-558.67%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q